Protagonist Therapeutics (PTGX) PT Raised to $137 at Citizens

May 6, 2026 4:28 AM

Citizens analyst Jonathan Wolleben raised the price target on Protagonist Therapeutics (NASDAQ: PTGX) to $137.00 (from $120.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found